Innocan Pharma Reports Positive Safety Results for LPT-CBD in Minipigs
Breakthrough Study Shows Promising Safety Profile Innocan Pharma Corporation, a frontrunner in the pharmaceutical and biotechnology sectors, has announced encouraging findings from a safety assessment study of its innovative drug, LPT-CBD. This study, which involved administering a single injection of LPT-CBD to Göttingen minipigs, aimed to evaluate the drug’s safety across three escalating doses. Over […]
The post Innocan Pharma Reports Positive Safety Results for LPT-CBD in Minipigs first appeared on CBD Telegraph.
* This article was originally published here
Comments
Post a Comment